J&J offers EU concessions for Synthes buy
February 22nd, 2012
BRUSSELS, Feb 22 (Reuters) – U.S. healthcare company
Johnson & Johnson has offered concessions in a bid to
ease EU regulatory concerns over its $21.3 billion purchase of
Swiss medical device maker…
